Trial · NCT00761657
Participant flow108
How many started, completed or left each group, period by period.
1 to 20 of 108
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part 1 (up to Day 57) | STARTED | Roxadustat 0.7 Milligrams/Kilograms (mg/kg) BIW | 0 | |
| Part 1 (up to Day 57) | STARTED | Roxadustat 0.7 mg/kg TIW | 0 | |
| Part 1 (up to Day 57) | STARTED | Roxadustat 1.0 mg/kg BIW | 12 | |
| Part 1 (up to Day 57) | STARTED | Roxadustat 1.0 mg/kg TIW | 10 | |
| Part 1 (up to Day 57) | STARTED | Roxadustat 1.5 mg/kg BIW | 0 | |
| Part 1 (up to Day 57) | STARTED | Roxadustat 1.5 mg/kg TIW | 0 | |
| Part 1 (up to Day 57) | STARTED | Roxadustat 2.0 mg/kg BIW | 1 | |
| Part 1 (up to Day 57) | STARTED | Roxadustat 2.0 mg/kg TIW | 2 | |
| Part 1 (up to Day 57) | STARTED | Placebo | 10 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 0.7 Milligrams/Kilograms (mg/kg) BIW | 0 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 0.7 mg/kg TIW | 0 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 1.0 mg/kg BIW | 12 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 1.0 mg/kg TIW | 9 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 1.5 mg/kg BIW | 0 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 1.5 mg/kg TIW | 0 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 2.0 mg/kg BIW | 1 | |
| Part 1 (up to Day 57) | Safety Population | Roxadustat 2.0 mg/kg TIW | 2 | |
| Part 1 (up to Day 57) | Safety Population | Placebo | 10 | |
| Part 1 (up to Day 57) | Efficacy Evaluable (EE) Population | Roxadustat 0.7 Milligrams/Kilograms (mg/kg) BIW | 0 | |
| Part 1 (up to Day 57) | Efficacy Evaluable (EE) Population | Roxadustat 0.7 mg/kg TIW | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00761657/flow